Novartis
-
Novartis discontinues hydroxychloroquine trial over enrollment challenges
World | Jun 20, 2020, 07:29 PM ISTSwiss drugmaker Novartis has announced to discontinue Hydroxychloroquine (HCQ) clinical trial over acute enrollment challenges that have made completion of the trial infeasible, and not because any safety issues were reported or efficacy conclusions made.
-
Novartis, Abbott among 4 pharma cos in CCI dock over alleged price-fixing
Business | Dec 14, 2017, 11:33 AM ISTThe Competition Commission of India has initiated probe against four drugmakers for alleged price fixing of a popular anti-diabetic drug.
-
Novartis appoints Citigroup as broker for Indian entity share sale
May 10, 2013, 10:19 AM ISTNew Delhi, May 10: Drug major Novartis India has said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share sale to reduce stake in the Indian entity."Novartis
-
Swiss firm Novartis decides not to invest on R&D in India after SC verdict
Apr 02, 2013, 06:45 AM ISTNew Delhi, April 2: The Supreme Court's rejection of Novartis's patent plea for cancer drug 'Glivec' was hailed by domestic pharma companies as a "landmark' verdict that will help the poor have easier access to